The aim of the study was to decipher the mechanisms and associated genetic determinants responsible for increased carbapenem resistance among Proteus mirabilis clinical isolates.
Methods:
The entire genetic structure surrounding the β-lactam resistance genes was characterized by PCR, gene walking, and DNA sequencing.
Results:
A series of clinical P. mirabilis isolates were consecutively recovered from different patients at the Military hospital of Sofia, Bulgaria. They showed variable levels of resistance to carbapenems. All isolates produced the same carbapenemase VIM-1 that was chromosomally encoded. We showed that increased resistance to carbapenems was related to an increased number of blaVIM-1 gene copies.
Conclusion:
We showed here that increased carbapenem resistance in P. mirabilis may result from increased expression of the blaVIM-1 carbapenemase gene through multiplication of its copy number.
Get full access to this article
View all access options for this article.
References
1.
VillarH.E., DanelF., and LivermoreD.M.. 1997. Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other β-lactams. J. Antimicrob. Chemother. 40:365–370.
2.
PaganiL., MigliavaccaR., PallecchiL., MattiC., GiacoboneE., AmicosanteG., RomeroE., and RossoliniG.M.. 2002. Emerging extended-spectrum β-lactamases in Proteus mirabilis. J. Clin. Microbiol. 40:1549–1552.
3.
HuY.Y., CaiJ.C., ZhangR., ZhouH.W., SunQ., and ChenG.X.. 2012. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital. Antimicrob. Agents Chemother. 56:2278–2282.
4.
BonnetR., MarchandinH., ChanalC., SirotD., LabiaR., De ChampsC., Jumas-BilakE., and SirotJ.. 2002. Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother. 46:2004–2006.
5.
PoirelL., SchrenzelJ., CherkaouiA., BernabeuS., RenziG., and NordmannP.. 2011. Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland. J. Antimicrob. Chemother. 66:1730–1733.
6.
VourliS., TsorliniH., KatsifaH., PolemisM., TzouvelekisL.S., KontodimouA., and VatopoulosA.C.. 2006. Emergence of Proteus mirabilis carrying the blaVIM-1 metallo-β-lactamase gene. Clin. Microbiol. Infect. 12:691–694.
7.
PapagiannitsisC.C., MiriagouV., KotsakisS.D., TzelepiE., VatopoulosA.C., PetinakiE., and TzouvelekisL.S.. 2012. Characterization of a transmissible plasmid encoding VEB-1 and VIM-1 in Proteus mirabilis. Antimicrob. Agents Chemother. 56:4024–4025.
8.
TsakrisA., IkonomidisA., PoulouA., SpanakisN., PournarasS., and MarkouF.. 2007. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-β-lactamase. J. Antimicrob. Chemother. 60:136–139.
9.
LoliA., TzouvelekisL.S., TzelepiE., CarattoliA., VatopoulosA.C., TassiosP.T., and MiriagouV.. 2006. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1. J. Antimicrob. Chemother. 58:669–672.
10.
PoirelL., DortetL., BernabeuS., and NordmannP.. 2011. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob. Agents Chemother. 55:5403–5407.
11.
Clinical and Laboratory Standards Institute. 2017. Performance standards for antimicrobial susceptibility testing: Twenty-seventh informational supplement M100-S27. CLSI, Wayne, PA.
12.
KieserT.1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid, 12:19–36.
13.
NordmannP., PoirelL., and DortetL.. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 18:1503–1507.
14.
PoirelL., GuibertM., GirlichD., NaasT., and NordmannP.. 1999. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob. Agents Chemother. 43:769–776.
15.
BontronS., PoirelL., and NordmannP.. 2016. Real-time PCR for detection of plasmid-mediated polymyxin resistance (mcr-1) from cultured bacteria and stools. J. Antimicrob. Chemother. 71:2318–2320.
16.
AragónL.M., MirelisB., MiróE., MataC., GomezL., RiveraA., ColiP., and NavarroF.. 2008. Increase in β-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type β-lactamases. J. Antimicrob. Chemother. 61:1029–1032.
17.
BonninR.A., PoirelL., SampaioJ.L., and NordmannP.. 2012. Complete sequence of broad-host-range plasmid pRIO-5 harboring the extended-spectrum-β-lactamase gene blaBES-1. Antimicrob. Agents Chemother. 56:1116–1119.
18.
MiriagouV., CarattoliA., TzelepiE., VillaL., and TzouvelekisL.S.. 2005. IS26-associated In4-type integrons forming multiresistance loci in enterobacterial plasmids. Antimicrob. Agents Chemother. 49:3541–3543.
19.
ZienkiewiczM., Kern-ZdanowiczI., CarattoliA., GniadkowskiM., and CeglowskiP.. 2013. Tandem multiplication of the IS26-flanked amplicon with the blaSHV-5 gene within plasmid p1658/97. FEMS Microbiol. Lett. 341:27–36.
20.
GirlichD., BonninR.A., BogaertsP., De LaveleyeM., HuangD.T., DortetL., GlaserP., GlupczynskiY., and NaasT.. 2017. Chromosomal amplification of the blaOXA-58 carbapenemase gene in a Proteus mirabilis clinical isolate. Antimicrob. Agents Chemother. 61:pii:e01697-16.
21.
GalaniI., SouliM., KoratzanisE., KoratzanisG., ChryssouliZ., and GiamarellouH.. 2007. Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece. J. Antimicrob. Chemother. 59:578–579.
22.
BertiniA., PoirelL., BernabeuS., FortiniD., VillaL., NordmannP., and CarattoliA.. 2007. Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:2324–2328.
23.
HeS., HickmanA.B., VaraniA.M., SiguierP., ChandlerM., DekkerJ.P., and DydaF.. 2015. Insertion sequence IS26 reorganizes plasmids in clinically isolated multidrug-resistant bacteria by replicative transposition. MBio, 6:e00762.
